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granuloma, most radiologists do not opt for 
a specific diagnosis. Depending on clinical 
findings, the differential diagnosis includes 
glioma, brain abscess and toxoplasmosis.
Investigations supporting a tuberculous 
aetiology include a positive tuberculin skin 
test, a chest radiograph suggestive of 
pulmonary tuberculosis and a cerebrospinal 
fluid (CSF) picture characteristic of 
tuberculous meningitis. Identification 
of acid-fast bacilli and culture of 
Mycobacterium tuberculosis from gastric 
washings and/or CSF specimens confirm a 
tuberculous aetiology. Serological tests are 
positive in only a small number of cases of 
neurocysticercosis and are generally not 
helpful in the diagnosis.
Management
If a diagnosis of tuberculoma is made, the 
treatment is 6 months of high-dose anti-
tuberculosis treatment, i.e. rifampicin 20 mg/
kg/day, isoniazid 20 mg/kg/day, ethionamide 
20 mg/kg/day and pyrazinamide 40 mg/kg/ 
 
day. Prednisone 2 mg/kg/day is given for 1 
month. It has previously been documented 
that most tuberculomas disappear after 
6 months of antituberculosis therapy. A 
repeat CT scan is therefore advocated after 
6 months of therapy.2 Treatment is complete 
once the lesion is no longer visible, is calcified 
or shows no contrast enhancement. It is 
important to remember that tuberculomas 
may paradoxically enlarge on treatment 
before reducing in size. 
Treatment of neurocysticercosis should 
be individualised and the decision to use 
anthelmintics should be based on the 
number, location and viability of the parasite 
in the central nervous system. There is no 
consensus regarding the use of anthelmintics 
in children with neurocysticercosis.1 
Arguments against treatment include 
CT-demonstrated enhancing lesions that 
represent dying parasites and lesions that 
tend to resolve spontaneously. There is 
some evidence that radiological clearance 
may be accelerated in children with viable 
lesions. However, this does not affect seizure 
recurrence. Albendazole has become the 
anthelmintic of choice and offers good CSF 
penetration.4 There is not enough evidence 
regarding the optimal dose or duration of 
treatment with albendazole. The published 
dose schedule is 15 mg/kg/day and short 
courses of 7 days or less are as effective 
as longer courses.5 Adverse events during 
treatment are common and include headache, 
dizziness and gastrointestinal symptoms. 
Corticosteroids are frequently used in 
children with multiple neurocysticercosis 
lesions because of the possibility of cerebral 
oedema after drug-induced cyst death. The 
drug of choice is either dexamethazone 
0.5 mg/kg/day or prednisone 1 mg/kg/day 
24 hours before anthelmintic treatment and 
for the duration of such treatment. There is 
some evidence that corticosteroids reduce 
adverse effects associated with albendazole. 
Children presenting with single lesions do 
not require steroid cover. 
There is consensus that anti-epileptic therapy 
is indicated in all children with symptomatic 
seizures and carbamazepine is the drug of 
choice. The starting dosage is 5 mg/kg/day in 
2 - 3 divided doses, increasing by increments 
of 5 mg/kg/day, if clinically indicated, to a 
recommended dosage of 15 - 20 mg/kg/day 
in 2 - 3 divided doses. Often therapy can be 
withdrawn after 6 months if the child remains 
seizure free. In such cases, repeat imaging is 
not recommended. If seizures recur after the 
acute phase of inflammation and involution 
of the cyst, a diagnosis of epilepsy should 
be considered, and anticonvulsant therapy 
should continue until a 2-year seizure-free 
period has elapsed. 
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Headache is a common problem in childhood 
– up to 25% of schoolchildren suffer from 
chronic, recurrent headaches. Although 
primary headaches are far more common 
than those with a secondary cause, it is the 
latter that result in the most anxiety for 
families.1 A logical approach to investigating 
and managing headaches is needed. 
Classification
According to the International Classification 
of Headache Disorders, 2nd ed., headaches are 
divided into those with primary and those 
with secondary causes. Primary headaches 
occur independently of any other medical 
condition, while secondary headaches are 
directly attributed to an underlying medical 
cause.2
History
A detailed history is vital to identify the 
characteristics of the headache and to exclude 
secondary causes. Pertinent questions that 
need to be answered are set out in Table I.1 
Examination
The general examination should include 
vital signs, including blood pressure and 
temperature. Meningitis should be excluded 
in all children with pyrexia. The skin must 
be examined for features of neurocutaneous 
syndromes. An increased head circumference 
may be a reflection of chronically raised 
intracranial pressure. Exclusion of other 
non-neurological causes entails examination 
of the ears, nose and throat (ENT), sinuses, 
teeth, temperomandibular joint and cervical 
spine. It is useful to evaluate visual acuity 
by means of a Snellen’s chart to exclude 
refractive errors that may cause headache.
Fig. 1. A CT scan showing neurocysticercosis 
with a calcified nodule representing a scolex, 
and surrounding oedema.
Fig. 2. Tuberculoma in the right midbrain 
showing ring enhancement after contrast 
administration.
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In addition to measuring the head 
circumference, clues in the neurological 
examination that indicate a secondary 
cause would include depressed or altered 
level of consciousness, meningism, 
papilloedema (useful in older children to 
confirm raised intracranial pressure) and 
focal signs, including cranial nerve palsies 
and hemiparesis. Headache associated with 
papilloedema and an abducens palsy as the 
only abnormal neurological finding is a 
common presentation of benign intracranial 
hypertension. 
In the majority of children presenting with 
headache the neurological examination will 
be completely normal. 
Investigations
Investigations should be guided by the history 
and clinical findings. Most headaches are 
idiopathic in nature. Brain tumour is a rare 
cause of headache in children – the incidence 
is 3 - 5 per 100 000, and of these only 10% will 
present with headache as the only symptom. 
Therefore, for every child with a brain 
tumour presenting with headache as the 
only feature, there are at least 50 000 children 
with recurrent headache.2 Investigating all 
children with chronic headache and a normal 
neurological examination by computed 
tomography (CT) scanning of the brain 
is therefore not a feasible option. Neuro-
imaging is nevertheless indicated in certain 
situations (Table II). Magnetic resonance 
imaging (MRI) is the neuro-imaging of 
choice, but in resource-limited settings CT is 
the logical alternative.
Management of primary headache
The management of headaches in children 
demands a multidisciplinary approach 
involving the general practitioner or 
paediatrician, schoolteacher, dietician and 
psychologist. Additionally, input from the 
family is essential to ensure successful treatment 
of a condition as complex as childhood 
headache. Management comprises both 
pharmacological and non-pharmacological 
approaches. Keeping a headache diary is 
Table I. Pertinent questions when evaluating a child with headache
Question Clinical features Likely diagnosis Management pointer
When did the headache start? Acute, non-progressive Local cause Not pathological, analgesics
Acute, evolving Possible brain tumour Refer, neuro-imaging
Chronic Migraine Non-pharmacological and  pharmacological 
approaches
Tension-type headache Analgesics
What is the pattern of headache? Intermittent Migraine Non-pharmacological and pharmacological 
approaches
Worsening Intracranial pathology Refer, neuro-imaging
Chronic, non-progressive Tension-type headache Analgesics
What is the headache frequency? Daily to few times a week Tension-type headache Analgesics
Weekly to monthly Migraine Non-pharmacological and  pharmacological 
approaches
Clusters of few times a 
week for a few weeks, long 
asymptomatic periods
Cluster headache Analgesics
Do the headaches occur at a specific 
time?
Night or early morning Migraine Non-pharmacological and  pharmacological 
approaches
Raised intracranial pressure Refer, neuro-imaging
Is an aura or prodrome present? Present Migraine Non-pharmacological and  pharmacological 
approaches
Intracranial pathology Refer, neuro-imaging
Where is the pain?  Unilateral persistent Secondary cause Refer, neuro-imaging
Bifrontal Migraine Non-pharmacological and  pharmacological 
approaches
Diffuse Tension-type headache Analgesics
Are there any associated symptoms? Intermittent nausea, vomit-
ing, photophobia
Migraine Non-pharmacological and  pharmacological 
approaches
Persistent nausea, vomiting, 
photophobia
Intracranial pathology Refer, neuro-imaging
Are there any aggravating or reliev-
ing factors?
Relief with analgesics Migraine, tension-type 
headache
Non-pharmacological and  pharmacological 
approaches
Relief with sleep Migraine Non-pharmacological and  pharmacological 
approaches
Worsened by light, noise, 
activity
Migraine Non-pharmacological and  pharmacological 
approaches
Worsened by lying down Raised intracranial pressure Refer, neuro-imaging
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useful, as it provides information regarding 
the pattern and frequency of headaches and 
response to interventions. Important non-
pharmacological strategies involve good 
sleep hygiene, regular exercise, decreasing 
the amount of caffeinated drinks and 
relaxation methods. Obtaining a history can 
be difficult in young children.3,4 Therefore, 
their drawings may be very useful in the 
diagnosis of headaches in children. In a large 
study, identification of elements of children’s 
drawings enabled differentiation between 
migraine, tension-type headache and other 
headaches (Figs 1 and 2).5   Diet may also play 
an important role in childhood headaches 
and is often ignored as a therapeutic option. 
Foodstuffs that can trigger headaches include 
cheese, chocolate, citrus fruits, monosodium 
glutamate, aspartame, ice-cream and alcohol. 
A headache and diet diary should be kept, 
and foods presumed to trigger attacks must 
then be excluded. However, eliminating all 
potential food triggers is generally not advised 
and a well-balanced diet is encouraged.6
The aim of acute pharmacological treatment 
is a rapid return to normal function with 
minimal side-effects.7 Ibuprofen 10 mg/kg/
dose was shown to be superior to placebo8,9 
and equivalent to acetaminophen 15 mg/
kg/dose in the management of migraine in 
children.8 If non-steroidals are not effective, 
serotonin-receptor agonists are an option. 
Nasal sumatriptan 10 mg (20 - 39 kg) 
and 20 mg (>39 kg) has been shown to be 
effective in an 8 - 17-year age group, as was 
rizatriptan 5 mg (20 - 39 kg) and 10 mg 
(>39 kg) in this age group.10,11 Analgesic 
headache occurs when drugs given for the 
treatment of headache aggravate headache 
symptoms. The condition is recognised in 
children and may even be induced by mild 
analgesics such as paracetamol used in 
isolation. The diagnosis is confirmed when 
abrupt withdrawal of analgesic drugs leads 
to headache resolution.12
Prophylactic therapy should be reserved 
for children with frequent headaches that 
interfere with daily lifestyle and result 
in functional disability. Prospective, 
randomised, controlled trials evaluating 
preventive treatment in children with 
migraine are scanty. The few studies 
published are hampered by placebo response 
rates as high as 50%.  Therapeutic options 
most often used include: amitriptyline 10 - 
25 mg at night, sodium valproate 20 mg/kg/
day given as either a single dose or 2 divided 
doses, topiramate 1 - 4 mg/kg/day (100 - 
200 mg/day) in 2 divided doses, propranolol 
2 - 4 mg/kg/day (10 - 40 mg three times 
daily) and levetiracetam 20 - 40 mg/kg/day 
in 2 divided doses. These therapeutic options 
are based on small studies, and the definitive 
agent has yet to be identified.
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Fig. 1. Drawing by a child with migraine.
Fig. 2. Drawing by a child with tension-type 
headache.
  Table II. Indications for neuro-imaging in children with headache
1.    Abnormal neurological examination (focal neurological signs, abnormal eye movements, ataxia, hemiparesis, papilloedema )
2.    Headache characteristics, such as headache on awakening; headache always occurring on the same side of the head; headache with change of 
posture/sneezing/coughing; unusual location (occipital headaches); headache causing sleep interruption; worst headache of life, chronic-progressive 
pattern
3.    Deterioration in school-work and personality change 
4.    Presence of ventriculoperitoneal  shunt
5.   Presence of neurocutaneous features
6.   Headache in child under 3 years of age
